From the databaseWhat the row says.
Every entry follows the same shape: what is happening, the mechanism, and the recommendation.
Scope
Supplement × Prescription
Last verified
June 4, 2026
CautionEmerging evidence
What is happening. Broad-spectrum and beta-lactam antibiotics can disrupt gut flora that synthesize vitamin K, theoretically reducing endogenous vitamin K availability. For most people on a short dicloxacillin course this is clinically negligible, but the effect is most relevant in patients on warfarin, where antibiotic-associated reductions in vitamin K can enhance anticoagulant effect.
Mechanism. Suppression of vitamin K-producing intestinal bacteria by the antibiotic can lower menaquinone (vitamin K2) supply; supplemental vitamin K offsets this but the interaction matters chiefly for vitamin-K-antagonist anticoagulation.
Recommendation. No routine action is needed for healthy individuals taking a vitamin K supplement. Patients on warfarin should have INR monitored during and after antibiotic therapy, as flora-related changes in vitamin K status can alter anticoagulation.
Stack Score
How it moves the number.
Effect on the composite score
If both Dicloxacillin and Vitamin K2 are in the same stack, this pair applies −5 to your Stack Score (per scored caution row).
The full algorithm, the clamping rules, and four worked stacks are at /methodology/stack-score.
SourcesSources, by evidence tier.
Every claim on this page is cited. PMIDs link straight to PubMed.
Reference material
2- 1Conly JM, Stein K. The production of menaquinones (vitamin K2) by intestinal bacteria and their role in maintaining coagulation homeostasis. Prog Food Nutr Sci. 1992.Needs sourceNo link
- 2Baillargeon J, et al. Concurrent use of warfarin and antibiotics and the risk of bleeding in older adults. Am J Med. 2012.Needs sourceNo link